Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 4
2019 2
2020 1
2021 3
2022 4
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Could it be VEXAS?
Guerineau H, Kohn M, Al Hamoud A, Sellier J, Osman J, Cabannes-Hamy A. Guerineau H, et al. Among authors: cabannes hamy a. Ann Hematol. 2024 Jun;103(6):2169-2171. doi: 10.1007/s00277-024-05750-8. Epub 2024 Apr 9. Ann Hematol. 2024. PMID: 38589717
Traitement par CAR-T des leucémies aiguës de l'adulte.
Rahal I, Cabannes-Hamy A, Boissel N. Rahal I, et al. Among authors: cabannes hamy a. Bull Cancer. 2018 Dec;105 Suppl 2:S158-S167. doi: 10.1016/S0007-4551(19)30046-3. Bull Cancer. 2018. PMID: 30686354 Review. French.
IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition.
Courtois L, Cabannes-Hamy A, Kim R, Delecourt M, Pinton A, Charbonnier G, Feroul M, Smith C, Tueur G, Pivert C, Balducci E, Simonin M, Angel LH, Spicuglia S, Boissel N, Andrieu GP, Asnafi V, Rousselot P, Lhermitte L. Courtois L, et al. Among authors: cabannes hamy a. Blood. 2023 Jul 13;142(2):158-171. doi: 10.1182/blood.2022017948. Blood. 2023. PMID: 37023368
PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax.
Pinton A, Courtois L, Doublet C, Cabannes-Hamy A, Andrieu G, Smith C, Balducci E, Cieslak A, Touzart A, Simonin M, Lhéritier V, Huguet F, Balsat M, Dombret H, Rousselot P, Spicuglia S, Macintyre E, Boissel N, Asnafi V. Pinton A, et al. Among authors: cabannes hamy a. Clin Cancer Res. 2024 Jan 5;30(1):94-105. doi: 10.1158/1078-0432.CCR-23-2159. Clin Cancer Res. 2024. PMID: 37889114
Clonal evolution in hereditary thrombocytosis with MPL T487A mutation.
Vasseur L, Favier R, Kim R, Rabian F, Cabannes-Hamy A, Cassinat B, Maslah N, Vasquez N, Clappier E, Kiladjian JJ, Boissel N. Vasseur L, et al. Among authors: cabannes hamy a. Pediatr Blood Cancer. 2023 Feb;70(2):e29905. doi: 10.1002/pbc.29905. Epub 2022 Aug 4. Pediatr Blood Cancer. 2023. PMID: 35924408 No abstract available.
Semen Cryopreservation in Adolescents and Young Adults with Hematologic Diseases: from Bed to Benchside.
Beauvais D, Berthaut I, Cabannes-Hamy A, Béhal H, Barraud-Lange DV, Pollet-Villard X, Lengliné E, Itzykson R, Andreoli A, Ricadat E, Dhédin N, Levy R, Poirot C, Boissel N. Beauvais D, et al. Among authors: cabannes hamy a. J Adolesc Young Adult Oncol. 2022 Aug;11(4):389-393. doi: 10.1089/jayao.2021.0137. Epub 2021 Nov 9. J Adolesc Young Adult Oncol. 2022. PMID: 34756112
Efficacy of ibrutinib in the treatment of Bing-Neel syndrome.
Cabannes-Hamy A, Lemal R, Goldwirt L, Poulain S, Amorim S, Pérignon R, Berger J, Brice P, De Kerviler E, Bay JO, Sauvageon H, Beldjord K, Mourah S, Tournilhac O, Thieblemont C. Cabannes-Hamy A, et al. Am J Hematol. 2016 Mar;91(3):E17-9. doi: 10.1002/ajh.24279. Am J Hematol. 2016. PMID: 26689870 Free article. No abstract available.
A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia.
Kohn M, Delord M, Chbat M, Guemriche A, Merabet F, Roupie AL, Lombion N, Farhat H, Longval T, Cabannes-Hamy A, Lambert J, Marque-Juillet S, Raggueneau V, Osman J, Spentchian M, Rigaudeau S, Rousselot P, Besson C. Kohn M, et al. Among authors: cabannes hamy a. Haematologica. 2022 Jun 1;107(6):1454-1459. doi: 10.3324/haematol.2021.280026. Haematologica. 2022. PMID: 34788987 Free PMC article. No abstract available.
High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL.
Cabannes-Hamy A, Brissot E, Leguay T, Huguet F, Chevallier P, Hunault M, Escoffre-Barbe M, Cluzeau T, Balsat M, Nguyen S, Pasquier F, Alexis M, Lheritier V, Pastoret C, Delabesse E, Clappier E, Dombret H, Boissel N. Cabannes-Hamy A, et al. Haematologica. 2022 Sep 1;107(9):2072-2080. doi: 10.3324/haematol.2021.280078. Haematologica. 2022. PMID: 35263986 Free PMC article.
20 results